In an ongoing effort to prevent and control infectious disease outbreaks globally, the U.S. Agency for International Development (USAID) and Becton, Dickinson and Company (BD), a leading global medical technology company, collaborates to strengthen Indonesia’s national reference laboratory systems. This new private/public partnership supports the National Tuberculosis (TB) Program (NTP), and will aim to improve and expand quality laboratory services. In particular, the collaboration will emphasize the early detection of TB cases, as well as monitoring and treatment services. Modeled after the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and BD’s Labs for Life program, the USAID/BD collaboration will introduce improved laboratory practices in 19 national reference laboratories supported by the NTP, which are conducting TB diagnostic services. BD will also train lab workers on the TB culture drug susceptibility testing, and together, USAID/BD will develop a nationally recognized accreditation and certification system for Indonesian laboratories and lab personnel.
|Location||Indonesia, East Asia and Pacific|
|Value||USD 1.5 Million|